CENPC

gene
On this page

Also known as CENP-Chcp-4MIF2

Summary

CENPC (centromere protein C, HGNC:1854) is a protein-coding gene on chromosome 4q13.2, encoding Centromere protein C (Q03188). Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. It is a selective cancer dependency (DepMap: 86.7% of cell lines).

Centromere protein C 1 is a centromere autoantigen and a component of the inner kinetochore plate. The protein is required for maintaining proper kinetochore size and a timely transition to anaphase. A putative pseudogene exists on chromosome 12.

Source: NCBI Gene 1060 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 170 total
  • Cancer dependency (DepMap): dependent in 86.7% of screened cell lines
  • MANE Select transcript: NM_001812

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1854
Approved symbolCENPC
Namecentromere protein C
Location4q13.2
Locus typegene with protein product
StatusApproved
AliasesCENP-C, hcp-4, MIF2
Ensembl geneENSG00000145241
Ensembl biotypeprotein_coding
OMIM117141
Entrez1060

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 4 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay

ENST00000273853, ENST00000506410, ENST00000506882, ENST00000507196, ENST00000510189, ENST00000513216, ENST00000515140, ENST00000910804, ENST00000929364, ENST00000960630

RefSeq mRNA: 2 — MANE Select: NM_001812 NM_001362481, NM_001812

CCDS: CCDS47063

Canonical transcript exons

ENST00000273853 — 19 exons

ExonStartEnd
ENSE000011565056746876267472675
ENSE000020366876754533867545503
ENSE000034813826751921767519502
ENSE000034890106750678867506934
ENSE000034972496751815667518368
ENSE000034977716753081567530914
ENSE000035056736751240267512569
ENSE000035108496749515967495212
ENSE000035441916750881467509105
ENSE000035496476753984067539934
ENSE000035563216749388467493988
ENSE000035709596751407467514687
ENSE000035916946754098067541050
ENSE000035953306748996767490121
ENSE000036030926750520567505284
ENSE000036040706747488867474978
ENSE000036088826749286967492997
ENSE000036412006754414967544195
ENSE000036917786749218067492275

Expression profiles

Bgee: expression breadth ubiquitous, 146 present calls, max score 96.48.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.1847 / max 108.5483, expressed in 1117 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
5230916.09481707
523087.89261586
523102.3479957
523110.8367451

Top tissues by expression

157 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370196.48gold quality
sural nerveUBERON:001548894.07gold quality
corpus callosumUBERON:000233692.50gold quality
bone marrow cellCL:000209292.27gold quality
bone marrowUBERON:000237192.11gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.26gold quality
tonsilUBERON:000237290.59gold quality
body of pancreasUBERON:000115088.98gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.58gold quality
ventricular zoneUBERON:000305388.01gold quality
adrenal tissueUBERON:001830387.29gold quality
lymph nodeUBERON:000002986.33gold quality
left ovaryUBERON:000211986.33gold quality
colonic epitheliumUBERON:000039786.32gold quality
pancreasUBERON:000126486.08gold quality
ovaryUBERON:000099285.84gold quality
endometriumUBERON:000129585.71gold quality
tibial nerveUBERON:000132384.56gold quality
uterine cervixUBERON:000000284.48gold quality
rectumUBERON:000105284.10gold quality
vaginaUBERON:000099684.07gold quality
right ovaryUBERON:000211883.94gold quality
minor salivary glandUBERON:000183083.81gold quality
saliva-secreting glandUBERON:000104483.80gold quality
thoracic mammary glandUBERON:000520083.67gold quality
gall bladderUBERON:000211083.60gold quality
uterusUBERON:000099583.50gold quality
thyroid glandUBERON:000204683.40gold quality
olfactory segment of nasal mucosaUBERON:000538683.36gold quality
duodenumUBERON:000211483.05gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.35

Regulation

Is transcription factor: no

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 86.7% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 29)

  • CENP-C may target the centromere by establishing multiple contacts with both the DNA and protein constituents of the kinetochore (PMID:12490152)
  • the interaction between CENP-B and CENP-C may be involved in the correct assembly of CENP-C on alphoid DNA (PMID:14612452)
  • CENPC target sites that can be sumoylated by SUMO-2 were shown to be equally susceptible to SUMO-1 attachments which include specific sites on SUMO-2 itself, Ubc9, and the recombinant CENP-C fragments (PMID:15272016)
  • a functional interplay between the chromosomal passenger complex and CENP-C. (PMID:17287400)
  • Using protein truncation and in vitro mutagenesis, we have identified the nucleolar localization sequences on CENPC1,and evidence shows that CENPC1 is an RNA-associating protein that binds alpha-satellite RNA by an in vitro binding assay. (PMID:17623812)
  • CENP-C and CENP-H co-localize to the CENP-A chromatin domain. (PMID:17651496)
  • DNMT3B interacts with CENP-C to modulate DNA methylation and the histone code at centromere. (PMID:19482874)
  • C-terminal domain of CENP-C displays multiple and critical functions for mammalian centromere formation (PMID:19503796)
  • Direct binding of Cenp-C to the Mis12 complex joins the inner and outer kinetochore. (PMID:21353556)
  • CENP-C works as an important factor for centromeric M18BP1 recruitment (PMID:22540025)
  • The CENP-A/histone H3.3 nucleosome forms an unexpectedly stable structure and allows the binding of the essential centromeric protein, CENP-C, which is ectopically mislocalized in the chromosomes of CENP-A overexpressing tumor cells. (PMID:25408271)
  • CENP-C recruits the Ndc80 complex through its interactions with KNL1 and the Mis12 complex at kinetochores during chromosome segregation. (PMID:25660545)
  • We used a synthetic system to dissect how CenH3(CENP-A) contributes to the accumulation of CENP-C and CENP-T, two key components that are necessary for the formation of functional kinetochores (PMID:25843710)
  • CENP-B directly binds both CENP-A’s amino-terminal tail and CENP-C, a key nucleator of kinetochore assembly (PMID:25942623)
  • CENP-C affects nucleosome shape and dynamics in a manner analogous to allosteric regulation of enzymes. CENP-C depletion leads to rapid removal of CENP-A from centromeres, indicating their collaboration in maintaining centromere identity. (PMID:25954010)
  • HPV18 E7 inhibited the binding of CENP-C to alpha-satellite DNAs. (PMID:25997930)
  • CENP-C, a CCAN subunit, is crucial for kinetochore assembly because it links centromeres with the microtubule-binding interface of kinetochores. (PMID:26124289)
  • CENP-C and CENP-I are key factors connecting kinetochore to CENP-A assembly. (PMID:26527398)
  • A nonhistone centromere protein, CENP-C, binds and reshapes the nucleosome, sliding the DNA gyres back to positions similar to those in canonical nucleosomes containing conventional histone H3. (PMID:26878239)
  • Upon cross-linking, the entire CENPA/CENPB/CENPC/CENPT complex is nuclease-protected over an alpha-satellite dimer that comprises the fundamental unit of centromeric chromatin. We conclude that CENPA/CENPC and CENPT pathways for kinetochore assembly are physically integrated over young alpha-satellite dimers. (PMID:27384170)
  • Whereas CENP-C recruits a single MIS12:NDC80 complex, the authors show here that CENP-T binds one MIS12:NDC80 and two NDC80 complexes upon phosphorylation by the mitotic CDK1:Cyclin B complex at three distinct CENP-T sites. (PMID:28012276)
  • Levels of centromere aberrations increase upon depletion of CENP-A, CENP-C, and CENP-T/W, during replicative senescence, and in cancer cells. (PMID:28167779)
  • CENP-C specifically binds alpha satellite non-coding RNAs. (PMID:28787590)
  • Collectively, these studies clarify how CENP-N and CENP-C decode and stabilize the non-canonical CENP-A nucleosome to enforce epigenetic centromere specification and kinetochore assembly. (PMID:29280735)
  • CENP-N stabilizes CENP-A nucleosomes alone and additively with CENP-C in vitro. However, removal of CENP-C and CENP-N from cells, or mutating CENP-A so that it no longer interacts with CENP-C or CENP-N, had no effect on centromeric CENP-A stability in vivo. Thus, the stability of CENP-A nucleosomes in chromatin does not arise solely from its interactions with CENP-C or CENP-N. (PMID:29343552)
  • two key conformational changes within the CENP-A nucleosome upon CENP-C binding, are reported. (PMID:31475439)
  • CDK1-mediated CENP-C phosphorylation modulates CENP-A binding and mitotic kinetochore localization (PMID:31676716)
  • A genetic memory initiates the epigenetic loop necessary to preserve centromere position. (PMID:32945564)
  • The Elusive Structure of Centro-Chromatin: Molecular Order or Dynamic Heterogenetity? (PMID:33065112)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosi:ch211-161h7.4ENSDARG00000087238
mus_musculusCenpc1ENSMUSG00000029253
rattus_norvegicusCenpcENSRNOG00000021776

Protein

Protein identifiers

Centromere protein CQ03188 (reviewed: Q03188)

Alternative names: Centromere autoantigen C, Centromere protein C 1, Interphase centromere complex protein 7

All UniProt accessions (3): Q03188, H0Y8J2, H0Y9W1

UniProt curated annotations — full annotation on UniProt →

Function. Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. CENPC recruits DNA methylation and DNMT3B to both centromeric and pericentromeric satellite repeats and regulates the histone code in these regions.

Subunit / interactions. Oligomer. Component of the CENPA-NAC complex, at least composed of CENPA, CENPC, CENPH, CENPM, CENPN, CENPT and CENPU. The CENPA-NAC complex interacts with the CENPA-CAD complex, composed of CENPI, CENPK, CENPL, CENPO, CENPP, CENPQ, CENPR and CENPS. Binds to DAXX. Interacts with DNMT3B. Interacts directly with CENPA. Identified in a centromere complex containing histones H2A, H2B and H4, and at least CENPA, CENPB, CENPC, CENPT, CENPN, HJURP, SUPT16H, SSRP1 and RSF1. Interacts with MEIKIN.

Subcellular location. Nucleus. Chromosome. Centromere. Kinetochore.

Domain organisation. The MIF2 homology domain II targets centromeres and binds the alpha satellite DNA in vivo. The MIF2 homology domain III can induce CENPC dimerization/oligomerization.

Similarity. Belongs to the CENP-C/MIF2 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q03188-11yes
Q03188-22

RefSeq proteins (2): NP_001349410, NP_001803* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011051RmlC_Cupin_sfHomologous_superfamily
IPR014710RmlC-like_jellyrollHomologous_superfamily
IPR025974Mif2/CENP-C_cupinDomain
IPR028052CENP-C_N_domDomain
IPR028386CENP-C/Mif2/cnp3Family
IPR028931CENP-C_midDomain

Pfam: PF11699, PF15620, PF15622

UniProt features (65 total): modified residue 21, cross-link 16, region of interest 8, compositionally biased region 7, short sequence motif 4, splice variant 2, sequence variant 2, strand 2, chain 1, sequence conflict 1, helix 1

Structure

Experimental structures (PDB)

17 structures.

PDBMethodResolution (Å)
7R5RELECTRON MICROSCOPY2.44
7PIIELECTRON MICROSCOPY2.68
28OPELECTRON MICROSCOPY2.7
5LSJX-RAY DIFFRACTION3.25
7XHOELECTRON MICROSCOPY3.29
6MUPELECTRON MICROSCOPY3.5
6SE6ELECTRON MICROSCOPY3.5
5LSKX-RAY DIFFRACTION3.5
9TAWELECTRON MICROSCOPY3.54
6MUOELECTRON MICROSCOPY3.6
6SEFELECTRON MICROSCOPY3.7
7XHNELECTRON MICROSCOPY3.71
6SEEELECTRON MICROSCOPY4.2
9TAXELECTRON MICROSCOPY4.5
7QOOELECTRON MICROSCOPY4.6
7YYHELECTRON MICROSCOPY8.9
7YWXELECTRON MICROSCOPY12

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q03188-F148.330.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (37): 73, 96, 130, 146, 183, 189, 225, 261, 316, 333, 376, 397, 439, 528, 538, 684, 709, 710, 734, 763 …

Function

Pathways and Gene Ontology

Reactome pathways

21 pathways

IDPathway
R-HSA-141444Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
R-HSA-2467813Separation of Sister Chromatids
R-HSA-2500257Resolution of Sister Chromatid Cohesion
R-HSA-5663220RHO GTPases Activate Formins
R-HSA-606279Deposition of new CENPA-containing nucleosomes at the centromere
R-HSA-68877Mitotic Prometaphase
R-HSA-9648025EML4 and NUDC in mitotic spindle formation
R-HSA-141424Amplification of signal from the kinetochores
R-HSA-162582Signal Transduction
R-HSA-1640170Cell Cycle
R-HSA-194315Signaling by Rho GTPases
R-HSA-195258RHO GTPase Effectors
R-HSA-2555396Mitotic Metaphase and Anaphase
R-HSA-68882Mitotic Anaphase
R-HSA-68886M Phase
R-HSA-69278Cell Cycle, Mitotic
R-HSA-69618Mitotic Spindle Checkpoint
R-HSA-69620Cell Cycle Checkpoints
R-HSA-73886Chromosome Maintenance
R-HSA-774815Nucleosome assembly
R-HSA-9716542Signaling by Rho GTPases, Miro GTPases and RHOBTB3

MSigDB gene sets: 182 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE, DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN, GOBP_CHROMOSOME_LOCALIZATION, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, chr4q13, PUJANA_CHEK2_PCC_NETWORK, GOBP_ORGANELLE_FISSION, GOBP_MITOTIC_NUCLEAR_DIVISION, GOBP_ORGANELLE_ASSEMBLY

GO Biological Process (6): mitotic cell cycle (GO:0000278), chromosome segregation (GO:0007059), cell division (GO:0051301), attachment of mitotic spindle microtubules to kinetochore (GO:0051315), kinetochore assembly (GO:0051382), spindle attachment to meiosis I kinetochore (GO:0051455)

GO Molecular Function (4): DNA binding (GO:0003677), centromeric DNA binding (GO:0019237), identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (11): kinetochore (GO:0000776), condensed chromosome, centromeric region (GO:0000779), inner kinetochore (GO:0000939), nucleus (GO:0005634), nucleoplasm (GO:0005654), pericentric heterochromatin (GO:0005721), cytosol (GO:0005829), nuclear body (GO:0016604), midbody (GO:0030496), chromosome, centromeric region (GO:0000775), chromosome (GO:0005694)

Reactome top-level categories

Rollup of top-14 pathways:

CategoryPathways
Cell Cycle3
Mitotic Prometaphase2
M Phase2
Amplification of signal from the kinetochores1
Mitotic Anaphase1
RHO GTPase Effectors1
Nucleosome assembly1
Mitotic Spindle Checkpoint1
Signaling by Rho GTPases, Miro GTPases and RHOBTB31
Signaling by Rho GTPases1
Mitotic Metaphase and Anaphase1
Cell Cycle, Mitotic1
Cell Cycle Checkpoints1
Chromosome Maintenance1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membraneless organelle3
cellular anatomical structure3
chromosome, centromeric region2
cell cycle1
mitotic nuclear division1
cell cycle process1
cellular process1
mitotic metaphase chromosome alignment1
attachment of spindle microtubules to kinetochore1
mitotic cell cycle process1
kinetochore organization1
protein-containing complex assembly1
membraneless organelle assembly1
meiotic metaphase I homologous chromosome alignment1
attachment of meiotic spindle microtubules to kinetochore1
nucleic acid binding1
sequence-specific double-stranded DNA binding1
protein binding1
binding1
condensed chromosome, centromeric region1
supramolecular complex1
condensed chromosome1
kinetochore1
protein-containing complex1
intracellular membrane-bounded organelle1
nuclear lumen1
heterochromatin1
cytoplasm1
nucleoplasm1
chromosomal region1

Protein interactions and networks

STRING

904 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CENPCCENPAP49450999
CENPCCENPHQ9H3R5995
CENPCCENPBP07199993
CENPCCENPTQ96BT3993
CENPCCENPSQ8N2Z9986
CENPCCENPNQ96H22986
CENPCDNMT3BQ9UBC3978
CENPCCENPUQ71F23970
CENPCCENPIQ92674966
CENPCCENPMQ9NSP4939
CENPCCENPWQ5EE01935
CENPCCENPLQ8N0S6928
CENPCCENPOQ9BU64922
CENPCCENPKQ9BS16917
CENPCCENPPQ6IPU0915

IntAct

136 interactions, top by confidence:

ABTypeScore
NPM1NVLpsi-mi:“MI:0914”(association)0.610
CENPCH1-5psi-mi:“MI:0915”(physical association)0.560
MIS12SPC24psi-mi:“MI:0914”(association)0.530
RBM34NVLpsi-mi:“MI:0914”(association)0.530
RRP8NVLpsi-mi:“MI:0914”(association)0.530
RPL18NOP56psi-mi:“MI:0914”(association)0.530
CENPCNDC80psi-mi:“MI:0914”(association)0.530
MACROH2A2PPM1Gpsi-mi:“MI:0914”(association)0.530
NRBM47psi-mi:“MI:0914”(association)0.530
RBM4NVLpsi-mi:“MI:0914”(association)0.530
NIFKRSL1D1psi-mi:“MI:0914”(association)0.530
ABT1ZNF316psi-mi:“MI:0914”(association)0.530
CENPHPSMD11psi-mi:“MI:0914”(association)0.530
MAGEB2GTPBP10psi-mi:“MI:0914”(association)0.530
RPL13RRP8psi-mi:“MI:0914”(association)0.530
CENPCCENPCpsi-mi:“MI:0915”(physical association)0.520
CENPCCENPApsi-mi:“MI:0915”(physical association)0.510
DDX21MED19psi-mi:“MI:2364”(proximity)0.480
CENPCDAXXpsi-mi:“MI:0915”(physical association)0.440

BioGRID (146): CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Proximity Label-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Affinity Capture-MS), CENPC (Proximity Label-MS), CENPC (Affinity Capture-MS), MIS12 (Affinity Capture-MS), DSN1 (Affinity Capture-MS)

ESM2 similar proteins: A1L2H3, A2AKX3, A5D8S0, B0S6S9, D3Z987, E1BC15, O43303, O60673, O95405, P56715, Q03188, Q2M2Z5, Q3MHH3, Q3V089, Q569L8, Q5BQN8, Q5CZC0, Q5DTT3, Q5R9I1, Q5VWN6, Q61493, Q641I1, Q6NS59, Q6NSW3, Q6ZP01, Q6ZU52, Q7TSH4, Q7Z333, Q7Z3T8, Q80U44, Q80U59, Q86UW6, Q86WS4, Q86XD8, Q8IXS0, Q8MJ03, Q8MJ04, Q8MJ06, Q8N1H7, Q8N7Z5

Diamond homologs: P49452, P49453, Q03188

SIGNOR signaling

2 interactions.

AEffectBMechanism
CENPC“up-regulates activity”“CENP-A nucleosome”binding
CENPC“form complex”“CCAN complex”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 133 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Nucleosome assembly633.6×3e-07
Amplification of signal from the kinetochores1023.2×3e-10
Peptide chain elongation1319.4×6e-12
Viral mRNA Translation1319.4×6e-12
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA1319.2×6e-12
Mitotic Spindle Checkpoint1018.7×2e-09
Formation of a pool of free 40S subunits1418.4×4e-12
Selenocysteine synthesis1318.4×9e-12

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation1422.0×2e-12
ribosomal large subunit biogenesis518.8×5e-04
chromosome segregation1217.7×1e-09
ribosomal small subunit biogenesis713.5×1e-04
negative regulation of translation711.6×2e-04
mitotic spindle organization511.5×4e-03
rRNA processing910.8×2e-05
translation1210.4×4e-07

Disease & clinical

Clinical variants and AI predictions

ClinVar

170 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance129
Likely benign12
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2894 predictions. Top by Δscore:

VariantEffectΔscore
4:67472579:A:ACdonor_gain1.0000
4:67472580:C:CCdonor_gain1.0000
4:67472639:T:Adonor_gain1.0000
4:67489959:GTACT:Gdonor_loss1.0000
4:67489961:ACTC:Adonor_loss1.0000
4:67489963:TCACC:Tdonor_loss1.0000
4:67489964:CACCA:Cdonor_loss1.0000
4:67489965:A:ACdonor_gain1.0000
4:67489966:C:CAdonor_gain1.0000
4:67489966:CCA:Cdonor_gain1.0000
4:67490122:C:CCacceptor_gain1.0000
4:67492847:A:ACdonor_gain1.0000
4:67492868:C:CCdonor_gain1.0000
4:67492892:AT:Adonor_gain1.0000
4:67492893:T:TAdonor_gain1.0000
4:67492944:T:TAdonor_gain1.0000
4:67492999:T:Aacceptor_loss1.0000
4:67493878:TTTTA:Tdonor_loss1.0000
4:67493879:TTTA:Tdonor_loss1.0000
4:67493880:TTAC:Tdonor_loss1.0000
4:67493881:TA:Tdonor_loss1.0000
4:67493882:A:Tdonor_loss1.0000
4:67493883:C:Adonor_loss1.0000
4:67493894:T:Adonor_gain1.0000
4:67493984:CAATA:Cacceptor_gain1.0000
4:67493985:AATA:Aacceptor_gain1.0000
4:67493986:ATA:Aacceptor_gain1.0000
4:67493987:TA:Tacceptor_gain1.0000
4:67493989:C:CCacceptor_gain1.0000
4:67495153:TCTTA:Tdonor_loss1.0000

AlphaMissense

6236 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
4:67472623:A:CF938L0.998
4:67472623:A:TF938L0.998
4:67472625:A:GF938L0.998
4:67472624:A:GF938S0.997
4:67472671:G:CN922K0.997
4:67472671:G:TN922K0.997
4:67474896:A:TV918D0.997
4:67490022:A:GL872S0.997
4:67490029:C:AG870W0.997
4:67472630:A:GL936P0.996
4:67472653:A:CN928K0.996
4:67472653:A:TN928K0.996
4:67474973:A:CF892L0.996
4:67474973:A:TF892L0.996
4:67474975:A:GF892L0.996
4:67474902:A:GF916S0.995
4:67489997:C:AK880N0.995
4:67489997:C:GK880N0.995
4:67489999:T:GK880Q0.995
4:67490028:C:TG870E0.995
4:67472611:T:AK942N0.994
4:67472611:T:GK942N0.994
4:67472635:A:CS934R0.994
4:67472635:A:TS934R0.994
4:67472637:T:GS934R0.994
4:67474948:A:GC901R0.994
4:67474953:A:GL899P0.994
4:67472630:A:TL936H0.993
4:67490028:C:AG870V0.993
4:67474901:G:CF916L0.992

dbSNP variants (sampled 300 via entrez): RS1000000868 (4:67531786 G>A,C), RS1000007497 (4:67469031 CAT>C), RS1000197376 (4:67484457 T>C), RS1000204883 (4:67529277 G>A), RS1000224111 (4:67491912 G>T), RS1000228827 (4:67525444 C>A,T), RS10002575 (4:67483283 G>A,C), RS10003115 (4:67520510 C>G,T), RS1000311832 (4:67469031 C>A,T), RS1000327847 (4:67541713 G>A), RS10003368 (4:67521343 T>C), RS1000368394 (4:67475439 C>A,T), RS1000427653 (4:67491725 A>G), RS1000436744 (4:67531537 T>C), RS1000506300 (4:67536859 T>C)

Disease associations

OMIM: gene MIM:117141 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST000266_10Multiple sclerosis (severity)4.000000e-06
GCST002826_10Urate levels (BMI interaction)2.000000e-06
GCST006921_13Regular attendance at a pub or social club7.000000e-09
GCST008476_34Emphysema annual change measurement in smokers (percent low attenuation area)9.000000e-06
GCST009028_15Adverse response to drug5.000000e-07
GCST010988_217Adult body size4.000000e-08
GCST011122_51Walking pace4.000000e-08

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004531urate measurement
EFO:0009592social interaction measurement
EFO:0007626emphysema imaging measurement
EFO:0009658adverse effect

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, decreases methylation3
perfluorooctane sulfonic aciddecreases expression2
aristolochic acid Idecreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
FR900359affects phosphorylation1
TAK-243decreases sumoylation1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
sodium arsenitedecreases expression, increases abundance1
coumarinincreases phosphorylation1
di-n-butylphosphoric acidaffects expression1
16-hydroxycleroda-3,13(14)-dien-15,16-olidedecreases expression1
Bortezomibincreases expression1
Sunitinibdecreases expression1
Arsenic Trioxideincreases expression1
Leflunomidedecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicdecreases expression, increases abundance1
Caffeineincreases phosphorylation1
Clorgylineincreases expression1
Doxorubicindecreases expression1
Estradioldecreases expression1
Formaldehydedecreases expression1
Quercetindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideaffects expression1
Aflatoxin B1decreases methylation1
Copper Sulfatedecreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.